St. Luke's Health System, Boise, Idaho Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02121769
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

St. Luke's Health System, Boise, Idaho | St. Luke’s Health System, Boise, Idaho

Active Ingredients

Drugs in Other Trials (1)

fish oil (Omegavan) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1